The impact of Sirolimus Eluting stents in interventional cardiology

International Journal of Cardiology

Volumn 95, Issue 2-3, 2004, Pages 117-121

  Di Mario, Carlo ^a   Griffiths, Huw ^a   O'Rourke, Brian ^a   Kaddoura, Sam ^a  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PACLITAXEL; RAPAMYCIN;

CLINICAL TRIAL; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY OBSTRUCTION; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG ELUTING STENT; EDITORIAL; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; PRIORITY JOURNAL; RESTENOSIS; SAFETY; THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT FAILURE; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY RESTENOSIS; COST-BENEFIT ANALYSIS; DRUG DELIVERY SYSTEMS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; SIROLIMUS; STENTS; TREATMENT OUTCOME;

EID: 2942581179     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2003.10.010     Document Type: Editorial

References (22)

1. Grube E., Gerskens G., Fitzgerald P., et al. Six months angiographic follow up with a Taxane coated stents in men. J. Am. Coll. Cardiol. 26:2001;31A
2. Kataoka T., Grube E., Honda Y., Morino Y., Hur S.H., Bonneau H.N., et al. 7-hexanoyltaxol-eluting stent for prevention of neointimal growth: an intravascular ultasound analysis from the study to compare restenosis rate between quest and quads QP2 (SCORE). Circulation. 106:2002;1788-1793
3. Liistro F., Stankovic G., Di Mario C., Colombo A. First clinical experience with a paclitaxel derivate-eluting polymer stent system implantation for in-stent restenosis: immediate and long-term clinical and angiographic outcome. Circulation. 105:2002;1883-1886
4. Virmani R., Liistro F., Stankovic G., Di Mario C., Montorfano M., Kolodgie F.D., et al. Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate eluting polymer stent system in humans. Circulation. 106:2002;2649-2651
5. Toutouzas K., Di Mario C., Falotico R., Takagi T., Stankovic G., Albiero R., et al. Sirolimus-Eluting stents: a review of experimental and clinical findings. Z. Kardiol. 91(Suppl 3):2002;49-57
6. Sousa J.E., Costa M.A., Sousa A.G., Abizaid A.C., Seixas A.C., Abizaid A.S., et al. Two-year angiographic and intravascular ultrasound follow-up after implantation of Sirolimus-Eluting stents in human coronary arteries. Circulation. 107:2003;381-383
7. Morice M.C., Serruys P.W., Sousa J.E., Fajadet J., Ban Hayashi E., Perin M., et al. RAVEL Study Group A randomized comparison of a Sirolimus-Eluting stent with a standard stent for coronary revascularization. N. Engl. J. Med. 346:2002;1773-1780
8. Morice M.C., Serruys P., Costantino C., Wuelfert E., Wijns W., Fajadet J., et al. on behalf of the RAVEL Trial Investigators Two-year follow-up of the RAVEL study: a randomized study with the Sirolimus-Eluting Bx VELOCITY stent in the treatment of patients with De Novo native coronary artery lesions. J. Am. Coll. Cardiol. 41:2003;32A
9. Holmes D.R. Jr., Leon M.B., Moses J.W., Midwall J., Clark M., Palacios I.F., et al. on behalf of the SIRIUS Trial Investigators One-year follow-up of the SIRIUS study. A randomized study with the sirolimus-eluting Bx VELOCITY ™ in the treatment of patients with De-Novo native coronary artery lesions. J. Am. Coll. Cardiol. 41:2003;32A
10. Serruys P.W., de Feyter P., Macaya C., Kokott N., Puel J., Vrolix M., et al. Lescol Intervenion Prevention Study (LIPS) Investigators Fluvastatin for prevention of cardiac events following success first percutaneous coronary intervention: a randomized controlled trial. JAMA. 287:2002;3215-3222
11. Leon M.B., Holmes D.R., Simonton C., Moses J.W., O'Shaughnessy C., Caputo R.P., et al. The impact of sirolimus-eluting stents in diabetics: results from the SIRIUS trial. J. Am. Coll. Cardiol. 41:2003;54A
12. Chow R.P., et al. Patency of internal thoracic artery grafts: comparison of right versus left and importance of vessel grafts. Circulation. 90(II):1994;129-132
13. Colombo A., Orlic D., Stankovic G., Corvaja N., Spanos V., Montorfano M., et al. Preliminary observations regarding angiographic pattern of restenosis after Rapamycin Eluting Stent implantation. Circulation. 107:2003;2178-2180
14. Sonoda S., Morino Y., Ako J., Hassan A., Reisman M., Wong S.C., et al. An optimal diagnostic threshold of minimum stent area to predict long-term stent patency following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis. J. Am. Coll. Cardiol. 41:2003;80A
15. Colombo A., Louvard Y., Raghu C., Di Mario C., Ludwig J., Leon M., et al. Sirolimus eluting stents in bifurcation lesions: 6 months angiographic result according to the implantation technique. J. Am. Coll. Cardiol. 41:2003;53A
16. Airoldi F., Spanos V., Stankovic G., Di Mario C., Chieffo A., Briguori C., et al. Bifurcational coronary artery lesion treatment with Rapamicine-Eluting Stents: results from a single center experience. J. Am. Coll. Cardiol. 41:2003;53
17. Tanabe K., Lemos P.A., Lee C.H., Degertekin M., Regar E., Arampatzis A.C., et al. The impact of Sirolimus-Eluting Stents on the outcome of patients with bifurcation lesions. J. Am. Coll. Cardiol. 41:2003;12A
18. Sousa J.E., Cost M.A., Abizaid A., Sousa A.G., Feres F., Mattos L.A., et al. Sirolimus-eluting stent for the treatment of in-stent restenosis quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation. 107:2003;24-27
19. Tanabe K., Muzaffer D., Regar E., Lee C.H., Smits P.C., van der Giessen W.J., et al. Thoraxcenter, Rotterdam, The Netherlands, Brigham and Woman's Hospital Boston, MA Sirolimus-Eluting Stent for treatment of in-stent restenosis: one-year angiographic and intravascular ultrasound follow-up. J. Am. Coll. Cardiol. 41:2003;12A
20. Saia F., Lemos P.A., Degertekin M., Regar E., Arampatzis C.A., Lee C.H., et al. Sirolimus-Eluting Stents for treatment of in-stent restenosis in the real world: preliminary results from the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry. J. Am. Coll. Cardiol. 41:2003;53A
21. Commeau P., Barragan P.Y., Roquebert P.O., Bouvier J.L., Comet B., Macaluso G., et al. Treatment of In-Stent Restenosis Using Sirolimus Eluting Stents: ISR II Registry. J. Am. Coll. Cardiol. 41:2003;53A
22. Cohen D.J., Bakhai A., Shi C., Githiora L., Berezin R.H., Caputo P., et al. on behalf of the SIRIUS Investigators Cost-Effectiveness of Sirolimus Drug-Eluting Stent the Treatment of Complex Coronary Stenosis: Res from the Randomized SIRIUS Trial. J. Am. Coll. Cardiol. 41:2003;32A